As a fully-integrated provider of solutions and services, Sharps Compliance’s solid business model, with strong margins and significant operating leverage, and early penetration into emerging markets, uniquely positions the company for strong future growth. With over 3 billion syringes disposed of annually outside of the hospital and large healthcare setting, the Company estimates that approximately 40 million of its mailback products would be needed to properly dispose of all used syringes in the small quantity generator market. The market for the Company’s products, which is believed to be penetrated by only 1%, is estimated at a total potential value of $1 billion.

Headquartered in Houston, Texas, Sharps focuses on targeted growth markets including healthcare, pharmaceutical, agriculture, hospitality, industrial, commercial, and retail. The Company’s flagship product, the Sharps Disposal by Mail System®, is a cost-effective and easy-to-use solution to dispose of medical waste such as hypodermic needles, lancets and any other medical device or objects used to puncture or lacerate the skin (referred to as “sharps”). The Company also offers a number of products specifically designed for the home healthcare market.

Supporting the community
Sharps is a leading proponent and participant in the development of public awareness and solutions for the safe disposal of needles, syringes and other sharps in the community setting.

Stock symbol
The Company's stock is traded on the NASDAQ under the symbol "SMED."

You may also access all of our filings with the Securities and Exchange Commission by clicking here.